AI-Driven Clinical Trials: The Trillion Dollar Market Expansion
Patient recruitment costs for oncology trials are out of control, eating up a huge chunk of research budgets…
Patient recruitment costs for oncology trials are out of control, eating up a huge chunk of research budgets…
The ambient clinical intelligence market is flooded with new solutions, but figuring out which ones will actually deliver…
AI’s first wave in healthcare crashed against the hard reality of clinical practice. Sepsis prediction models were the…
AI in diagnostic imaging isn’t just a promise anymore. It’s a reality that’s supposed to deliver faster read…
Generative AI is a big deal in healthcare, but for VCs and health system CIOs, the real question…
While the buzz around AI in healthcare usually focuses on big clinical breakthroughs, investors looking for real ROI…
Uncontrolled hypertension is a global health crisis, but for investors, it’s simpler: it’s an economic problem that costs…
Cardiac care is flipping from a reactive model to a proactive one, and machine learning is what’s driving…
Medication non-adherence in hypertension isn’t a small problem, it costs healthcare systems billions of dollars, worsens patient outcomes,…
The real opportunity in cardiovascular AI isn’t just about spotting heart attacks anymore, it’s about getting ahead of…